From Foundations to Fulfillment
For cancer care in North Texas, 2005–2015 was a defining decade. Ten years ago the Harold C. Simmons Comprehensive Cancer Center set the loftiest of goals – to meet the community’s many and varied cancer-related needs through:
- Outstanding achievement in biomedical research
- Exceptional patient care
- A rich training environment for the physicians and scientists of tomorrow
- Aggressive outreach to provide more North Texans with life-saving prevention and early detection
In just five years, the Simmons Comprehensive Cancer Center earned National Cancer Institute (NCI) designation recognizing achievement in those areas, a milestone that also has opened some of the most advanced national clinical trials to local cancer patients. And in 2015, after just another five years, Simmons was awarded “comprehensive” designation from the NCI, becoming one of only three such top-tier institutions in the state, and the only one in North Texas. The designation recognizes superior cancer care and prevention programs, along with pace-setting science and technology.
Those strides testify to the commitment of the Cancer Center’s scientific and clinical members, now more than 275 in total – the people behind the ideas, inspiration, industry, and innovation that propel progress in the lab, the clinic, and the community. But this achievement also was not possible without a vanguard of visionaries who had set in place the cornerstones upon which today’s Cancer Center has been built. Learn about the foundation for the Simmons Comprehensive Cancer Center.
Timeline of Achievement
In 1988, a $41 million gift from Dallas businessman Harold Simmons and his wife, Annette, provided seminal funds to transform cancer research and care at UT Southwestern. In 1991, the Harold C. Simmons Comprehensive Cancer Center was established. Learn about the Simmons Comprehensive Cancer Center's many achievements.
The Decade Ahead
Important advances over the next decade will help Simmons Comprehensive Cancer Center realize the power and the promise of precision medicine for North Texas cancer patients. These key areas of progress include:
- Delivery of radiation therapy
- Clinical trials leadership
- Cross-disciplinary collaboration
- Drug development
- Innovative discovery
- A UT Southwestern genomic panel